相关实验视频

Updated: Jul 25, 2025

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

在小细胞肺癌中,YTHDF2与瘤免疫透有负相关性

Gang Chen¹, Dandan Ren², Yuanhan Wang³

¹Department of Esophageal Mediastinal and Lymphatic Oncology (Chemoradiotherapy), Zhongnan Hospital of Wuhan University, Wuhan, Hubei, P.R. China.

Journal of molecular histology

|June 25, 2023

概括

YTHDF2是小细胞肺癌 (SCLC) 中的一个关键RNA调节剂. 高YTHDF2表达与生存率差相关,而低表达与增加的免疫细胞透和SCLC潜在的亚型过渡有关.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
免疫学免疫学免疫学

背景情况:

越来越多地认识到RNA修饰,特别是N6-甲基氨酸 (m6A),它们在癌症发展中的作用.
一种m6A读者蛋白质YTHDF2影响RNA稳定性,转录和翻译,这表明它可能在瘤发生中发挥作用.

研究的目的:

研究YTHDF2在小细胞肺癌 (SCLC) 的预后价值和功能作用.
探索YTHDF2表达,SCLC分子亚型和瘤免疫微环境 (TIME) 之间的关联.

主要方法:

对两个SCLC患者队列 (n=20和n=48) 的回顾性分析.
使用Kaplan-Meier,Log-rank测试和Cox回归的预后评估.
基因组丰富分析 (GSEA) 用于途径选.
对m6A相关基因与SCLC亚型和TIME的相关性分析.
使用多重免疫光学 (mIF) 验证免疫透.

主要成果:

YTHDF2被确定为SCLC的独立预后因素,高表达与较低的整体存活率相关.
低YTHDF2表达与从神经内分泌向非神经内分泌SCLC亚型的过渡相关.
减少YTHDF2表达与增加的免疫细胞透,免疫检查点和SCLC瘤中CD4+/CD8+T细胞的存在显著相关.

结论:

YTHDF2作为SCLC的潜在预后生物标志物.
YTHDF2的表达与SCLC中的瘤免疫透相反相关,这表明它在调节抗瘤免疫反应中的作用.

关键词:

免疫系统的透.预测预后预测预测小细胞肺癌是一种小细胞肺癌.这就是YTHDF2的原因.m6A 一个很好的.

更多相关视频

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...